[Effect of recombinant human erythropoietin--rHu-EPO on the metabolism of children treated by long-term hemodialysis].

Recombinant human erythropoietin (EPO) was administered to 12 children with terminal renal failure aged 8-17 years subjected to hemodialysis for a mean period of 16 (S.D. = 19.

[Effect of using recombinant human erythropoietin on the effectiveness of hemodialysis in children with terminal renal failure].

Recombinant human erythropoietin (EPO) was administered to 12 children aged 8-17 years subjected to hemodialysis for a mean period of 16 (S.D. 19.